Open AccessThe effects of duloxetine augmentation on clozapine in the treatment of negative symptoms in treatment resistant schizophrenia
Author(s) -
Ritvij Satodiya
Publication year - 2022
Language(s) - English
DOI - 10.52803/22123irn
Subject(s) - clozapine , schizophrenia (object oriented programming) , duloxetine , negative symptom , quality of life (healthcare) , psychiatry , medicine , psychology , clinical psychology , psychosis , psychotherapist , alternative medicine , pathology
The negative symptoms of schizophrenia have always been a challenge in treatment. The intensity and chronicity of these symptoms has direct impact on the life quality and treatment response. Current psychopharmacological agents have not offered a satisfactory result in addressing the negative symptoms of schizophrenia. The clinicians struggle with the approaches that can be utilized to target the negative symptoms of schizophrenia as no well-defined evidence exist. We present a case of treatment resistant schizophrenia with negative symptoms that responded well with augmentation of Duloxetine to Clozapine treatment.